Nonalcoholic fatty liver disease risk in polycystic ovary syndrome patients
Saved in:
| Main Authors: | Ana M. Fernández-Alonso, Peter Chedraui, Faustino R. Pérez-López |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Gynecological Endocrinology |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09513590.2024.2359031 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.
by: Balachandran Kumarendran, et al.
Published: (2018-03-01) -
The association between phenotypes of polycystic ovary syndrome and metabolic dysfunction-associated fatty liver disease
by: So-hyeon Hong, et al.
Published: (2025-08-01) -
Metabolic Syndrome in Adults with Nonalcoholic Fatty Liver Disease
by: Zhahid Hassan, et al.
Published: (2021-09-01) -
Nonalcoholic Fatty Liver Disease
by: Branka Filipović, et al.
Published: (2018-01-01) -
Biochemical, sex hormonal, and anthropometric predictors of non-alcoholic fatty liver disease in polycystic ovary syndrome
by: Xintong Li, et al.
Published: (2025-03-01)